George Tidmarsh left the agency amid accusations of misusing his authority and after clashing with another top official.
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
The Food and Drug Administration says it will remove a long-standing warning from hormone-based drugs used to treat menopause ...
The “plausible mechanism” pathway, outlined by Martin Makary and Vinay Prasad, is designed to help accelerate treatments ...
A new industry group is calling for the Food and Drug Administration to set a uniformed standard around additives.